ZIVO (Zivo Bioscience) Moat Score: 2/10 (As of Jul. 06, 2026)


ZIVO Zivo Bioscience Inc ZIVO
8 GF Score
Price $5.25
! 5 Warning Signs
View Full Analysis

What is Zivo Bioscience Moat Score?

Zivo Bioscience ZIVO +25.00% 8 Moat Score is 2 as of Jul. 06, 2026. GuruFocus rates ZIVO with a GF Score™ of 8/100. The stock has 5 warning signs investors should review. Among 1,395 Biotechnology companies, Zivo Bioscience ranks better than 58.28% on this metric.

Zivo Bioscience has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Zivo Bioscience has No Moat: Zivo Bioscience lacks significant market share, brand strength, or proprietary technology, resulting in a very weak competitive position with no discernible moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Zivo Bioscience might have No Moat - Very weak/transient advantages.

Zivo Bioscience  (OTCPK:ZIVO) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Zivo Bioscience Moat Score Related Terms

ZIVO vs ATOS, QNCX, AEON: Moat Score Comparison

For the Biotechnology subindustry, Zivo Bioscience's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zivo Bioscience Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zivo Bioscience's Moat Score distribution charts can be found below:

* The bar in red indicates where Zivo Bioscience's Moat Score falls into.


ZIVO
8GF Score
Zivo Bioscience Inc ZIVO
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Zivo Bioscience (ZIVO) has a Moat Score of 2 as of Jul. 06, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Zivo Bioscience ranks #582 out of 1395 companies in the Biotechnology industry, placing it in the top 41.7%.
Is Zivo Bioscience's Moat Score too high?
Zivo Bioscience's current Moat Score is 2. The Biotechnology industry median Moat Score is 2.00. Zivo Bioscience's value of 2 is 0% at this industry median. Based on the distribution chart, Zivo Bioscience ranks #582 out of 1395 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Zivo Bioscience has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Zivo Bioscience's Moat Score compare to ATOS and QNCX?
According to the Biotechnology industry distribution chart, Zivo Bioscience ranks #582 out of 1395 companies for Moat Score. This puts Zivo Bioscience in the upper half of its industry. The industry median Moat Score is 2.00. Zivo Bioscience's value of 2 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,395 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zivo Bioscience's current Moat Score of 2 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zivo Bioscience's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zivo Bioscience stock overvalued right now?
Zivo Bioscience (ZIVO) has a current Moat Score of 2. The current Moat Score is 2 and 0% at the Biotechnology industry median of 2.00. Zivo Bioscience's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Zivo Bioscience (ZIVO), the current Moat Score is 2 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zivo Bioscience Business Description

Address 2125 Butterfield Drive, Suite 100, Troy, MI, USA, 48084
Zivo Bioscience Inc operates in one reportable segment microalgae technology. The segment is research and development operating in both the therapeutic and nutritional sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's applications are ANIMAL APPLICATIONS, HUMAN APPLICATIONS.
8GF Score

Get the complete analysis for ZIVO

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.25
Price